These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11073749)

  • 1. Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens.
    Norrby-Teglund A; Ihendyane N; Kansal R; Basma H; Kotb M; Andersson J; Hammarström L
    Clin Infect Dis; 2000 Nov; 31(5):1175-82. PubMed ID: 11073749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Newton DW; Andersson J; Andersson U; Kotb M
    J Immunol; 1996 Apr; 156(8):3057-64. PubMed ID: 8609429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Varying titers of neutralizing antibodies to streptococcal superantigens in different preparations of normal polyspecific immunoglobulin G: implications for therapeutic efficacy.
    Norrby-Teglund A; Basma H; Andersson J; McGeer A; Low DE; Kotb M
    Clin Infect Dis; 1998 Mar; 26(3):631-8. PubMed ID: 9524835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different preparations of intravenous immunoglobulin vary in their efficacy to neutralize streptococcal superantigens: implications for treatment of streptococcal toxic shock syndrome.
    Schrage B; Duan G; Yang LP; Fraser JD; Proft T
    Clin Infect Dis; 2006 Sep; 43(6):743-6. PubMed ID: 16912949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of serum IgM antibodies against superantigens of Staphylococcus aureus and Streptococcus pyogenes in Kawasaki disease.
    Matsubara K; Fukaya T; Miwa K; Shibayama N; Nigami H; Harigaya H; Nozaki H; Hirata T; Baba K; Suzuki T; Ishiguro A
    Clin Exp Immunol; 2006 Mar; 143(3):427-34. PubMed ID: 16487241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcal superantigen-induced expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and reduced immunoglobulin release.
    Davies FJ; Olme C; Lynskey NN; Turner CE; Sriskandan S
    Clin Exp Immunol; 2019 Jul; 197(1):83-94. PubMed ID: 30815853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of immunoglobulins (IgG, IgA, IgM) in Antarctic summer expeditioners and their relationship with seasickness.
    Mishra KP; Yadav AP; Shweta ; Chanda S; Majumdar D; Ganju L
    Cell Immunol; 2011; 271(1):29-35. PubMed ID: 21714963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent immunoglobulin significantly attenuated the formation of IL-1β in Escherichia coli-induced sepsis in pigs.
    Barratt-Due A; Sokolov A; Gustavsen A; Hellerud BC; Egge K; Pischke SE; Lindstad JK; Pharo A; Castellheim A; Thorgersen EB; Mollnes TE
    Immunobiology; 2013 May; 218(5):683-9. PubMed ID: 22947599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.
    Norrby-Teglund A; Kaul R; Low DE; McGeer A; Andersson J; Andersson U; Kotb M
    Infect Immun; 1996 Dec; 64(12):5395-8. PubMed ID: 8945593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of disease associated autoantibodies by an immunoglobulin M- and immunoglobulin A-enriched human intravenous immunoglobulin preparation.
    Bar-Dayan Y; Bonnin E; Bloch M; Schweitzer R; Ravid M; Kazatchkine MD; Kaveri SV
    Scand J Immunol; 2000 Apr; 51(4):408-14. PubMed ID: 10736114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of the effects of betamethasone butyrate propionate, vitamin D3 derivatives, and cyclosporine on human lymphocyte-proliferation stimulated with a hemolytic streptococci-derived superantigen.
    Arai K; Uchiyama T; Okubo Y; Tsuboi R; Oka K; Hirano T
    Eur J Pharmacol; 2007 Oct; 571(2-3):222-30. PubMed ID: 17628528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A dynamic observation on serum cytokine and immunoglobulin (IgG, IgA, IgM) in patients with esophageal cancer].
    Tang RG; Yuan XH; Tang TT; Tang XQ; Hang YQ; Qin HJ; Chen HM; Fang WZ; Long XK
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():35-8. PubMed ID: 17767855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Usefulness of antibodies against A60 mycobacterial antigen in tuberculosis diagnosis].
    Zielonka TM; Demkow U; Filewska M; Białas-Chromiec B; Boros P; Załeska J; Radzikowska E; Radziukiewicz-Byszewska D
    Pol Merkur Lekarski; 2002 Jun; 12(72):486-90. PubMed ID: 12362667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contamination of IgG preparation for intravenous use with IgA. I. Development of ELISA tests for determination of low concentrations of IgAc, IgA1, IgA2, IgG and IgM].
    Dovezenski N; Velicković Z; Tosić Lj; Nikolić G; Popović O; Romić M; Djokić M; Mijusković Z
    Srp Arh Celok Lek; 1994; 122 Suppl 1():49-50. PubMed ID: 18173186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of immunoglobulin M-enriched intravenous immunoglobulins against bacterial infections and on the neutralization of bacterial toxins].
    Dichtelmüller H; Stephan W
    Arzneimittelforschung; 1987 Nov; 37(11):1273-6. PubMed ID: 3440036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commercial IgG immunoglobulin preparations exhibit IgG and IgA autoantibody reactivity at pharmacologic but not at physiologic concentrations.
    Gleicher N; Harlow L
    Mt Sinai J Med; 1990 Sep; 57(4):242-8. PubMed ID: 2123297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.